Peer Review reports
From: Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma
| Original Submission | ||
|---|---|---|
| 12 Feb 2018 | Submitted | Original manuscript |
| 20 Jun 2018 | Reviewed | Reviewer Report - Rose-Marie Amini |
| 10 Jul 2018 | Reviewed | Reviewer Report - Reviewer 2 |
| 7 Aug 2018 | Author responded | Author comments - Ting-Xun Lu |
| Resubmission - Version 2 | ||
| 7 Aug 2018 | Submitted | Manuscript version 2 |
| 11 Aug 2018 | Reviewed | Reviewer Report - Rose-Marie Amini |
| 15 Sep 2018 | Author responded | Author comments - Shuang Wu |
| Resubmission - Version 3 | ||
| 15 Sep 2018 | Submitted | Manuscript version 3 |
| 28 Sep 2018 | Author responded | Author comments - Shuang Wu |
| Resubmission - Version 4 | ||
| 28 Sep 2018 | Submitted | Manuscript version 4 |
| Publishing | ||
| 8 Oct 2018 | Editorially accepted | |
| 19 Oct 2018 | Article published | 10.1186/s12885-018-4914-4 |
You can find further information about peer review here.